TF
The startup develops a specialized cannula designed for minimally invasive cardiopulmonary bypass surgery, aimed at preventing patient injury during extracorporeal circulation. This device enhances safety by minimizing the risk of complications associated with traditional surgical methods.
Updated 2 months ago
Funding
$4.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MIFunding rounds are not available yet.
Founders
Product
Features
- The startup develops a specialized cannula designed for minimally invasive cardiopulmonary bypass surgery, aimed at preventing patient injury during extracorporeal circulation. This device enhances safety by minimizing the risk of complications associated with traditional surgical methods.